About the Conference
The 4th International Conference on Pharmaceutics and Advanced Drug Delivery Systems, taking place on June 14–15, 2027, in Barcelona, Spain, will bring together researchers, academicians, pharmaceutical scientists, clinicians, industry professionals, and students from around the world. The conference provides a platform to present current research, exchange scientific knowledge, and discuss developments in pharmaceutics, drug formulation, drug delivery technologies, nanomedicine, biologics, personalized medicine, and regulatory sciences.
The conference program features keynote lectures, plenary sessions, oral and poster presentations, and interactive discussions that encourage collaboration between academia, healthcare, and the pharmaceutical industry. Participants will have the opportunity to share research findings, explore practical applications, establish professional networks, and contribute to advancing pharmaceutical science and innovative drug delivery systems.
Why Attend?
Participating in the 4th International Conference on Pharmaceutics and Advanced Drug Delivery Systems
The 4th International Conference on Pharmaceutics and Advanced Drug Delivery Systems, taking place on June 14–15, 2027, in Barcelona, Spain, will bring together researchers, academicians, pharmaceutical scientists, clinicians, industry professionals, and students from around the world. The conference provides a platform to present current research, exchange scientific knowledge, and discuss developments in pharmaceutics, drug formulation, drug delivery technologies, nanomedicine, biologics, personalized medicine, and regulatory sciences.
The conference program features keynote lectures, plenary sessions, oral and poster presentations, and interactive discussions that encourage collaboration between academia, healthcare, and the pharmaceutical industry. Participants will have the opportunity to share research findings, explore practical applications, establish professional networks, and contribute to advancing pharmaceutical science and innovative drug delivery systems.
Why Attend?
Participating in the 4th International Conference on Pharmaceutics and Advanced Drug Delivery Systems
(Pharma 2027) is an excellent opportunity to stay informed about current developments in pharmaceutical sciences and drug delivery technologies. Connect with pharmaceutical scientists, researchers, academicians, clinicians, industry professionals, and regulatory experts from around the world to exchange knowledge, discuss emerging research, and explore practical solutions for improving healthcare.
By attending, you will:
- Learn about recent advances in pharmaceutics and advanced drug delivery systems.
- Present your research to an international scientific audience.
- Network with leading researchers and establish global collaborations.
- Explore innovations in drug formulation, nanomedicine, biologics, and targeted drug delivery.
- insights through keynote lectures, technical sessions, and scientific discussions.
- Contribute to the advancement of pharmaceutical research and healthcare
Who Should Attend?
Pharma 2027 welcomes participants from academia, healthcare, research organizations, and the pharmaceutical industry, including
- Pharmaceutical Scientists and Researcher
- Pharmacologists and Clinical Researchers
- Drug Delivery and Formulation Scientists
- Medicinal Chemists and Biotechnologists
- Clinical Pharmacists and Healthcare Professionals
- Academicians, Professors, Postdoctoral Fellows, and Students
- Regulatory Affairs and Quality Assurance Professionals
- Pharmaceutical Manufacturing and R&D Experts
- Biotechnology and Pharmaceutical Industry Representatives
- Young Researchers, Exhibitors, Sponsors, and Industry Partners
Scientific Sessions and Track
Track 1: Pharmaceutics and Pharmaceutical Sciences
This track focuses on the development, formulation, evaluation, and manufacturing of pharmaceutical products. It covers advances in dosage form design, pharmaceutical technologies, quality assurance, and drug development to improve the safety, efficacy, and performance of medicines
Track 2: Advanced Drug Delivery Systems
This track highlights innovative approaches for delivering therapeutic agents with improved precision, efficacy, and safety. It focuses on emerging drug delivery platforms, controlled release technologies, targeted therapies, and strategies that enhance patient outcomes and treatment effectiveness.
Advanced Drug Delivery Systems | Targeted Drug Delivery | Controlled Release | Sustained Release | Smart Drug Delivery | Site-Specific Delivery | Drug Carriers | Nanocarriers | Liposomes
Track 3: Novel Drug Formulation Technologies
This track focuses on innovative formulation approaches that improve drug stability, solubility, bioavailability, and therapeutic performance. It highlights emerging technologies for developing safe, effective, and patient-friendly pharmaceutical products.
Novel Drug Formulation | Pharmaceutical Formulations | Formulation Development | Drug Solubility | Bioavailability Enhancement | Solid Dispersions | Amorphous Formulations | Nanoformulations | Lipid-Based Formulations | Controlled Release Formulation
Track 4: Targeted and Site-Specific Drug Delivery
This track explores advanced drug delivery strategies that transport therapeutic agents directly to specific tissues, cells, or organs. It focuses on improving treatment efficacy, minimizing side effects, and enhancing precision through innovative targeting technologies.
Targeted Drug Delivery | Site-Specific Drug Delivery | Precision Drug Delivery | Targeted Therapeutics | Ligand-Based Targeting | Receptor-Mediated Drug Delivery | Nanocarriers | Liposomes
Track 5: Oral Drug Delivery
This track focuses on the development of oral dosage forms and delivery systems that improve drug absorption, stability, bioavailability, and patient compliance. It highlights innovative formulation strategies for effective and reliable oral drug administration.
Oral Drug Delivery | Oral Dosage Forms | Tablets | Capsules | Oral Suspensions | Controlled Release | Sustained Release | Immediate Release | Drug Absorption | Bioavailability | Gastrointestinal Drug Delivery
Track 6: Ocular Drug Deliver
This track focuses on advanced drug delivery systems designed for the treatment of eye diseases and disorders. It covers innovative formulations and delivery technologies that improve ocular bioavailability, therapeutic efficacy, and patient compliance. Discussions will include conventional and emerging ophthalmic dosage forms, sustained and controlled release systems, nanotechnology-based ocular delivery, ocular implants, and strategies to overcome physiological barriers for effective drug transport to anterior and posterior eye tissues.
Ocular Drug Delivery | Ophthalmic Drug Delivery | Eye Drug Delivery | Ophthalmic Formulations | Ocular Therapeutics | Eye Drops | Ocular Implants | Intraocular Drug Delivery
Track 7: Biopharmaceutics and Pharmacokinetics
This track focuses on the relationship between drug formulation, absorption, distribution, metabolism, and excretion to optimize therapeutic outcomes. It covers advances in biopharmaceutics, pharmacokinetic modeling, bioavailability studies, and dosage regimen design, supporting the development of safe, effective, and high-quality pharmaceutical products.
Biopharmaceutics | Pharmacokinetics | Drug Absorption | Drug Distribution | Drug Metabolism | Drug Excretion | ADME | Bioavailability | Bioequivalence | Pharmacokinetic Modeling
Track 8: Pharmacodynamics and Drug Metabolism
This track focuses on the mechanisms of drug action and the metabolic processes that influence drug efficacy and safety. It covers drug–receptor interactions, pharmacological responses, metabolic pathways, enzyme-mediated drug metabolism, and factors affecting therapeutic outcomes to support the development of effective pharmaceutical therapies.
Pharmacodynamics | Drug Metabolism | Drug Action | Drug–Receptor Interactions | Pharmacological Response | Metabolic Pathways | Drug Biotransformation | Cytochrome P450
Track 9: Liposomes, Micelles, and Nanocarriers
This track focuses on the design, development, and application of nanoscale drug delivery systems for improving therapeutic efficacy and targeted drug delivery. It covers liposomes, micelles, polymeric and lipid-based nanocarriers, surface-modified nanoparticles, and emerging nanotechnologies that enhance drug stability, bioavailability, and controlled release.
Liposomes | Micelles | Nanocarriers | Polymeric Nanoparticles | Lipid Nanoparticles | Solid Lipid Nanoparticles | Nanocapsules | Nanoemulsions | Dendrimers | Surface-Modified Nanocarriers | Targeted Drug Delivery | Controlled Drug Release | Nanomedicine
Track 10: 3D Printing in Pharmaceutical Manufacturing
This track explores the application of 3D printing technologies in pharmaceutical manufacturing for the development of personalized medicines and advanced dosage forms. It covers innovative printing techniques, formulation design, customized drug delivery systems, process
optimization, and regulatory considerations that support the future of pharmaceutical production.
3D Printing | Pharmaceutical Manufacturing | Additive Manufacturing | Personalized Medicine | Customized Dosage Forms | Drug Formulation | Pharmaceutical Printing | Drug Delivery Systems
Track 11: Theranostics and Combination Therapies
This track focuses on integrated therapeutic and diagnostic approaches that enable personalized and targeted treatment strategies. It covers theranostic platforms, combination drug therapies, multifunctional drug delivery systems, molecular imaging, and precision medicine to improve treatment efficacy, disease monitoring, and patient outcomes.Theranostics | Combination Therapies | Targeted Therapy | Personalized Medicine | Precision Medicine | Molecular Imaging | Diagnostic Imaging | Image-Guided Therapy | Drug–Diagnostic Combinations
Track 12: Quality by Design (QbD) in Pharmaceutical Development
This track focuses on the systematic application of Quality by Design (QbD) principles to develop robust, safe, and high-quality pharmaceutical products. It covers risk-based product and process development, critical quality attributes, process optimization, analytical approaches, and regulatory expectations to ensure consistent product quality throughout the pharmaceutical lifecycle.
Quality by Design (QbD) | Pharmaceutical Development | Quality Risk Management | Critical Quality Attributes (CQAs) | Critical Process Parameters (CPPs) | Design of Experiments (DoE) | Process Analytical Technology (PAT)
Track 13: Pharmacovigilance and Drug Safety
This track focuses on the detection, assessment, monitoring, and prevention of adverse drug reactions to ensure the safe and effective use of medicines. It covers drug safety surveillance, risk management, regulatory reporting, post-marketing monitoring, and emerging approaches to improve patient safety and regulatory compliance.
Pharmacovigilance | Drug Safety | Adverse Drug Reactions (ADRs) | Drug Safety Monitoring | Post-Marketing Surveillance | Signal Detection | Risk Management | Medication Safety
Track 14: Smart Drug Delivery Systems
This track focuses on intelligent drug delivery technologies that respond to biological, chemical, or physical stimuli for controlled and targeted therapeutic release. It covers responsive biomaterials, nanotechnology-based carriers, precision drug delivery, and advanced systems designed to improve treatment efficacy, minimize side effects, and enhance patient outcomes.
Smart Drug Delivery Systems | Stimuli-Responsive Drug Delivery | Targeted Drug Delivery | Controlled Drug Release | Intelligent Drug Carriers | Nanocarriers | Responsive Biomaterials
Track 15: Clinical Pharmacy and Translational Research
This track highlights the integration of pharmaceutical research with clinical practice to improve patient care and therapeutic outcomes. It covers clinical pharmacy, translational medicine, pharmacotherapy, personalized treatment strategies, medication management, and the translation of laboratory discoveries into clinical applications.
Clinical Pharmacy | Translational Research | Pharmacotherapy | Clinical Pharmacology | Patient Care | Medication Management | Personalized Medicine | Therapeutic Drug Monitoring
Track 16: RNA-Based Therapeutics
This track focuses on the development and application of RNA-based medicines for the prevention and treatment of diseases. It covers mRNA technologies, siRNA, miRNA, antisense oligonucleotides, RNA delivery systems, and emerging therapeutic approaches that are transforming modern pharmaceutical research.
RNA-Based Therapeutics | mRNA Therapeutics | siRNA | miRNA | Antisense Oligonucleotides | RNA Delivery Systems | Gene Silencing | Gene Therapy | Lipid Nanoparticles
Track 17: Pharmacodynamics and Drug Metabolism
This track focuses on the mechanisms of drug action and the metabolic processes that influence drug efficacy and safety. It covers drug–receptor interactions, metabolic pathways, enzyme-mediated metabolism, and factors affecting therapeutic response, supporting the development of safe and effective medicines.
Pharmacodynamics | Drug Metabolism | Drug Action | Drug–Receptor Interactions | Pharmacological Response | ADME | Drug Biotransformation | Cytochrome P450 | Enzyme Kinetics
Track 18: Polymeric Drug Delivery Systems
This track highlights the use of polymer-based materials for the controlled and targeted delivery of therapeutic agents. It covers biodegradable polymers, polymeric nanoparticles, hydrogels, drug-loaded implants, and advanced polymer technologies that improve drug stability, release, and therapeutic performance.
Polymeric Drug Delivery | Biodegradable Polymers | Polymeric Nanoparticles | Hydrogels | Drug-Loaded Polymers | Controlled Drug Release | Sustained Release | Smart Polymers
Track 19: Vaccine Delivery Systems
This track focuses on innovative vaccine delivery technologies that enhance immune responses, improve vaccine stability, and increase accessibility. It includes nanoparticle-based vaccines, mucosal delivery, adjuvants, controlled-release systems, and next-generation vaccine platforms.
Vaccine Delivery Systems | Vaccine Formulation | Nanoparticle Vaccines | Lipid Nanoparticles | mRNA Vaccines | DNA Vaccines | Vaccine Adjuvants | Controlled Vaccine Release
Track 20: Gene and Nucleic Acid Delivery
This track explores delivery technologies for genes and nucleic acids to support gene therapy and precision medicine. It covers viral and non-viral vectors, genome editing, RNA and DNA delivery platforms, and nanotechnology-based systems for efficient and targeted therapeutic applications.
Gene Delivery | Nucleic Acid Delivery | Gene Therapy | DNA Delivery | RNA Delivery | mRNA Therapeutics | siRNA | miRNA | CRISPR-Cas9 | Viral Vectors | Non-Viral Vectors | Lipid Nanoparticles
Market Analysis Report
The global Advanced Drug Delivery Systems (ADDS) market is projected to reach approximately USD 375 billion by 2027, growing at a compound annual growth rate (CAGR) of around 7.5%. Market expansion is driven by the increasing prevalence of chronic diseases, rising investments in pharmaceutical research and development, and growing demand for targeted and personalized therapies. Continuous advancements in nanotechnology, biologics, gene and RNA therapeutics, and smart drug delivery platforms are accelerating innovation across the pharmaceutical industry.The adoption of controlled-release formulations, lipid and polymeric nanoparticles, 3D printing, and AI-assisted drug development is transforming the design and delivery of modern medicines. North America continues to dominate the market due to its strong pharmaceutical and biotechnology sectors, while the Asia-Pacific region is expected to experience the fastest growth, supported by expanding healthcare infrastructure, increasing clinical research, and rising pharmaceutical manufacturing activities.
Key Market Highlights:
- Market Size (2027): Approximately USD 375 Billion
- CAGR: 7.5%
- Largest Market: North America
- Fastest-Growing Region: Asia-Pacific
- Key Growth Drivers: Targeted drug delivery, nanotechnology, biologics, RNA therapeutics, and controlled-release formulations
- Emerging Trends: AI in pharmaceutical development, 3D printing, smart drug delivery systems, gene therapy, and precision medicine
- Major End Users: Pharmaceutical companies, biotechnology firms, research institutes, hospitals, and academic organizations